Here's Why Momentum in Ventyx Biosciences, Inc. (VTYX) Should Keep goingZacks Investment Research • 01/25/23
Wall Street Analysts Predict a 71% Upside in Ventyx Biosciences, Inc. (VTYX): Here's What You Should KnowZacks Investment Research • 01/04/23
Ventyx Biosciences Announces Dosing of the First Patient in the Phase 2 SERENITY Trial of VTX958 for the Treatment of Moderate to Severe Plaque PsoriasisGlobeNewsWire • 12/01/22
Ventyx Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 11/03/22
Ventyx Biosciences to Report Third Quarter 2022 Financial Results on November 3, 2022GlobeNewsWire • 10/27/22
Ventyx Biosciences, Inc. (VTYX) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 10/24/22
These Are the Five Best and Worst Performing Small-cap Stocks in September 202224/7 Wall Street • 10/22/22
Bristol Myers Sotyktu Approval Sends Ventyx Stock Soaring: Consider Buying BothSeeking Alpha • 09/23/22
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This YearInvestors Business Daily • 09/19/22
Ventyx Biosciences, Inc. (VTYX) CEO Raju Mohan on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/16/22
Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 08/15/22
Ventyx Biosciences Announces Positive Topline Phase 1 Data for Its Selective Allosteric TYK2 Inhibitor VTX958GlobeNewsWire • 08/15/22
Ventyx Biosciences to Report Topline Results from the Phase 1 trial of its TYK 2 Inhibitor VTX958 and Second Quarter 2022 Financial Results on August 15, 2022GlobeNewsWire • 08/11/22
Ventyx Biosciences Announces Positive Topline Phase 1 Data for its Peripheral NLRP3 Inhibitor VTX2735GlobeNewsWire • 06/29/22
Ventyx Biosciences' (VTYX) CEO Raju Mohan on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
Ventyx Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 05/12/22
Ventyx Biosciences to Report First Quarter 2022 Financial Results on May 12, 2022GlobeNewsWire • 05/05/22
Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 03/23/22